Unknown

Dataset Information

0

BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.


ABSTRACT: The bromodomain protein, BRD4, has been identified recently as a therapeutic target in acute myeloid leukemia, multiple myeloma, Burkitt's lymphoma, NUT midline carcinoma, colon cancer, and inflammatory disease; its loss is a prognostic signature for metastatic breast cancer. BRD4 also contributes to regulation of both cell cycle and transcription of oncogenes, HIV, and human papilloma virus (HPV). Despite its role in a broad range of biological processes, the precise molecular mechanism of BRD4 function remains unknown. We report that BRD4 is an atypical kinase that binds to the carboxyl-terminal domain (CTD) of RNA polymerase II and directly phosphorylates its serine 2 (Ser2) sites both in vitro and in vivo under conditions where other CTD kinases are inactive. Phosphorylation of the CTD Ser2 is inhibited in vivo by a BRD4 inhibitor that blocks its binding to chromatin. Our finding that BRD4 is an RNA polymerase II CTD Ser2 kinase implicates it as a regulator of eukaryotic transcription.

SUBMITTER: Devaiah BN 

PROVIDER: S-EPMC3345009 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2757088 | biostudies-literature
| S-EPMC118035 | biostudies-literature
| S-EPMC4217226 | biostudies-literature
| S-EPMC109013 | biostudies-literature
| S-EPMC5392693 | biostudies-literature
| S-EPMC10519987 | biostudies-literature
| S-EPMC2132451 | biostudies-literature
| S-EPMC3497735 | biostudies-literature
| S-EPMC316402 | biostudies-literature
| S-EPMC8377744 | biostudies-literature